Cited by 1,924Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyAbdominal Surgery and Complications

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Open access

Russell, James A., Walley, Keith R., Singer, Joel, Gordon, Anthony C., Hébert, Paul C., Cooper, D. James, Holmes, Cheryl L., Mehta, Sangeeta, Granton, John T., Storms, Michelle M., Cook, Deborah J., Presneill, Jeffrey J., Ayers, Dieter·2008·New England Journal of Medicine

DOI 10.1056/nejmoa067373

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that low-dose vasopressin as compared with norepinephrine would decrease mortality among patients with septic shock who were being treated with conventional (catecholamine) vasopressors. METHODS: In this multicenter, randomized, double-blind trial, we assigned patients who had septic shock and were receiving a minimum of 5 microg of norepinephrine per minute to receive either low-dose vasopressin (0.01 to 0.03 U per minute) or norepinephrine (5 to 15 microg per minute) in addition to open-label vasopressors. All vasopressor infusions were titrated and tapered according to protocols to maintain a target blood pressure. The primary end point was the mortality rate 28 days after the start of infusions. RESULTS: A total of 778 patients underwent randomization, were infused with the study drug (396 patients received vasopressin, and 382 norepinephrine), and were included in the analysis. There was no significant difference between the vasopressin and norepinephrine groups in the 28-day mortality rate (35.4% and 39.3%, respectively; P=0.26) or in 90-day mortality (43.9% and 49.6%, respectively; P=0.11). There were no significant differences in the overall rates of serious adverse events (10.3% and 10.5%, respectively; P=1.00). In the prospectively defined stratum of less severe septic shock, the mortality rate was lower in the vasopressin group than in the norepinephrine group at 28 days (26.5% vs. 35.7%, P=0.05); in the stratum of more severe septic shock, there was no significant difference in 28-day mortality (44.0% and 42.5%, respectively; P=0.76). A test for heterogeneity between these two study strata was not significant (P=0.10). CONCLUSIONS: Low-dose vasopressin did not reduce mortality rates as compared with norepinephrine among patients with septic shock who were treated with catecholamine vasopressors. (Current Controlled Trials number, ISRCTN94845869 [controlled-trials.com].).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa067373

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
(1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00025 · Cited by 5,134
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,309
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,038
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310

Flagged first, then by citations

Show all 36 references

Research works printed but not linked: 2

Argenziano M, 1997, Circulation, 96, II
Chen JM, 1999, Circulation, 100, II

Sorted by citations

Items 101–200 of 999

Cardiac Vasoplegia Syndrome: Pathophysiology, Risk Factors and Treatment
Omar, S. A., Zedan, A., & NUGENT, K. M. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000341 · Cited by 172
Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database
Vincent, J., Nielsen, N. D., Shapiro, N. I., Gerbasi, M. E., Grossman, A., Doroff, R., Zeng, F., Young, P. J., & Russell, J. A. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0448-9 · Cited by 174
Self-citation
Vasopressor dose equivalence: A scoping review and suggested formula
Goradia, S., Sardaneh, A. A., Narayan, S. W., Penm, J. H.-D., & Patanwala, A. E. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.11.002 · Cited by 175
Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers
Knaup, H., Stahl, K., Schmidt, B. M. W., Idowu, T. O., Busch, M., Wiesner, O., Welte, T., Haller, H. G., Kielstein, J. T., Hoeper, M. M., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2220-9 · Cited by 174
Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials
Nagendran, M., Russell, J. A., Walley, K. R., Brett, S. J., Perkins, G. D., Hajjar, L., Mason, A. J., Ashby, D., & Gordon, A. C. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05620-2 · Cited by 161
Self-citation
Timing of vasopressor initiation and mortality in septic shock: a cohort study
Beck, V., Chateau, D., Bryson, G. L., Pisipati, A., Zanotti, S., Parrillo, J. E., Kumar, A., & The Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group (2014) · Critical Care · doi:10.1186/cc13868 · Cited by 161
Update of Sepsis in the Intensive Care Unit
Genga, K. R., & Russell, J. A. (2017) · Journal of Innate Immunity · doi:10.1159/000477419 · Cited by 167
Self-citation
Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy
Mancl, E. E., & Muzevich, K. M. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112470460 · Cited by 155
Acute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies
Gameiro, J., Fonseca, J. A., Outerelo, C., & Lopes, J. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061704 · Cited by 192
Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic Review
Santacruz, C. A., Pereira, A. J., Celis, É., & Vincent, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004000 · Cited by 155
Current practice and evolving concepts in septic shock resuscitation
Bakker, J., Kattan, E., Annane, D., Castro, R., Cecconi, M., Backer, D. D., Dubín, A., Evans, L., Gong, M. N., Hamzaoui, O., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06595-9 · Cited by 158
Self-citation
Interaction Between Fluids and Vasoactive Agents on Mortality in Septic Shock
Waechter, J. E., Kumar, A., Lapinsky, S. E., Marshall, J. C., Dodek, P., Arabi, Y. M., Parrillo, J. E., Dellinger, R. P., & Garland, A. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000520 · Cited by 152
Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis
Boyd, J. H., Fjell, C. D., Russell, J. A., Sirounis, D., Cirstea, M. S., & Walley, K. R. (2016) · Journal of Innate Immunity · doi:10.1159/000442976 · Cited by 157
Self-citation
Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis
Stolk, R. F., van der Poll, T., Angus, D. C., van der Hoeven, J. G., Pickkers, P., & Kox, M. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0862cp · Cited by 153
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial
Laterre, P.-F., Berry, S. M., Blemings, A., Carlsen, J. E., François, B., Graves, T., Jacobsen, K., Lewis, R. J., Opal, S. M., Perner, A., et al. (2019) · JAMA · doi:10.1001/jama.2019.14607 · Cited by 147
Self-citation
Pathophysiology of Septic Shock
Russell, J. A., Rush, B. N. M., & Boyd, J. H. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.08.005 · Cited by 147
Self-citation
EFFICACY AND SAFETY OF DOPAMINE VERSUS NOREPINEPHRINE IN THE MANAGEMENT OF SEPTIC SHOCK
Patel, G. P., Grahe, J. J. S., Sperry, M., Singla, S., Elpern, E. H., Lateef, O., & BALK, R. A. (2010) · Shock · doi:10.1097/shk.0b013e3181c6ba6f · Cited by 141
Vasopressin in Pediatric Vasodilatory Shock: A Multicenter Randomized Controlled Trial
Choong, K. L. M., BOHN, D. J., Fraser, D. D., Gaboury, I., Hutchison, J. S., Joffe, A. R., Litalien, C., Menon, K., McNamara, P. J., & Ward, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0221oc · Cited by 144
Safety of the Peripheral Administration of Vasopressor Agents
Lewis, T. C., Merchan, C., Altshuler, D., & Papadopoulos, J. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066616686035 · Cited by 149
Targeting HMGB1 in the treatment of sepsis
Wang, H., Ward, M. F., & Sama, A. E. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.863876 · Cited by 144
A global perspective on vasoactive agents in shock
Annane, D., Ouanes-Besbes, L., Backer, D. D., Du, B., Gordon, A. C., Glenn Hernández, P., Olsen, K. M., Osborn, T. M., Peake, S., Russell, J. A., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5242-5 · Cited by 147
Self-citation
Toxicities of CD19 CAR‐T cell immunotherapy
Hirayama, A. V. V., & Turtle, C. J. (2019) · American Journal of Hematology · doi:10.1002/ajh.25445 · Cited by 144
The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients
Boerma, E. C., & İnce, C. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1970-x · Cited by 139
Sepsis and septic shock: Pathogenesis and treatment perspectives
Minasyan, H. A. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.04.015 · Cited by 146
Modern trends in fluid therapy for burns
Tricklebank, S. (2009) · Burns · doi:10.1016/j.burns.2008.09.007 · Cited by 137
Personalizing blood pressure management in septic shock
Kato, R., & Pinsky, M. R. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0085-5 · Cited by 144
Sepsis-Associated Acute Kidney Injury: Macrohemodynamic and Microhemodynamic Alterations in the Renal Circulation
Prowle, J. R., & Bellomo, R. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.007 · Cited by 138
Management of critically-ill cirrhotic patients
Ginès, P., Fernández, J., Durand, F., & Saliba, F. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60003-8 · Cited by 136
Vascular leak in sepsis: physiological basis and potential therapeutic advances
McMullan, R. R., McAuley, D. F., O’Kane, C. M., & Silversides, J. A. (2024) · Critical Care · doi:10.1186/s13054-024-04875-6 · Cited by 147
[Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)]
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C.-E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · BORIS (University Library Bern) · doi:10.48350/654 · Cited by 129
Vasopressin and its analogues in shock states: a review
Demiselle, J., Fage, N., Radermacher, P., & Asfar, P. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-0628-2 · Cited by 137
Part 10: Paediatric basic and advanced life support
de Caen, A. R., Kleinman, M. E., Chameides, L., Atkins, D. L., Berg, R. A., Berg, M., Bhanji, F., Biarent, D., Bingham, R. M., Coovadia, A. H., et al. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.028 · Cited by 133
Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial
Liu, Z.-M., Chen, J., Kou, Q., Lin, Q., Huang, X., Tang, Z., Kang, Y., Li, K., Zhou, L., Song, Q., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5267-9 · Cited by 127
Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: Propensity score-based analysis of a before-after cohort study
Kim, W., Jo, E., Eom, J. S., Mok, J., Kim, M., Kim, K. U., Park, H.-K., Lee, M. K., & Lee, K. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.07.004 · Cited by 132
Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock*
Sacha, G. L., Lam, S. W., Wang, L., Duggal, A., Reddy, A. J., & Bauer, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005317 · Cited by 135
Vasoconstrictor Responses to Vasopressor Agents in Human Pulmonary and Radial Arteries
Currigan, D. A., Hughes, R. J. A., Wright, C. E., Angus, J. A., & Soeding, P. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000430 · Cited by 129
Acute kidney injury
Lameire, N. H., Biesen, W. V., & Vanholder, R. C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61794-8 · Cited by 129
Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials
Neto, A. S., Nassar, A. P., Cardoso, S. O., Manetta, J. A., Pereira, V. G., Espósito, D. C., Damasceno, M. C. T., & Russell, J. A. (2012) · Critical Care · doi:10.1186/cc11469 · Cited by 128
Self-citation
Reading between the (guide)lines—the KDIGO practice guideline on acute kidney injury in the individual patient
Okusa, M. D., & Davenport, A. (2013) · Kidney International · doi:10.1038/ki.2013.378 · Cited by 129
Clinical applications of intravenous immunoglobulins (IVIg) – beyond immunodeficiencies and neurology
Hartung, H.-P., Mouthon, L., Ahmed, R. A., Jordan, S. C., Laupland, K. B., & Jolles, S. R. A. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04024.x · Cited by 127
Net ultrafiltration intensity and mortality in critically ill patients with fluid overload
Murugan, R., Balakumar, V., Kerti, S. J., Priyanka, P., Chang, C. H., Clermont, G., Bellomo, R., Palevsky, P. M., & Kellum, J. A. (2018) · Critical Care · doi:10.1186/s13054-018-2163-1 · Cited by 124
Prävention, Diagnose, Therapie und Nachsorge der Sepsis
Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C. E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · Der Anaesthesist · doi:10.1007/s00101-010-1719-5 · Cited by 135
Comparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trial
Torgersen, C., Dünser, M. W., Wenzel, V., Jochberger, S., Mayr, V. D., Schmittinger, C. A., Lorenz, I. H., Schmid, S. W., Westphal, M., Grander, W., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1630-1 · Cited by 125
One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response
Wacharasint, P., Boyd, J. H., Russell, J. A., & Walley, K. R. (2013) · Critical Care · doi:10.1186/cc12794 · Cited by 126
Self-citation
Challenges with Diagnosing and Managing Sepsis in Older Adults
Clifford, K. M., Dy‐Boarman, E. A., Haase, K. K., Maxvill, K., Pass, S. E., & Álvarez, C. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1135052 · Cited by 132
Sepsis: Current Definition, Pathophysiology, Diagnosis, and Management
Taeb, A. M., Hooper, M. H., & Marik, P. E. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617695243 · Cited by 133
Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?
Yarnell, C. J., Abrams, D. C., Baldwin, M. R., Brodie, D., Fan, E., Ferguson, N. D., Hua, M. S., Madahar, P., McAuley, D. F., Munshi, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30471-9 · Cited by 119
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citation
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 128
Vasopressors in septic shock: which, when, and how much?
Shi, R., Hamzaoui, O., Vita, N. D., Monnet, X., & Teboul, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.04.24 · Cited by 126
The Interaction of Vasopressin and Corticosteroids in Septic Shock
Gordon, A. C., Mason, A. J., Perkins, G. D., Stotz, M., Terblanche, M., Ashby, D., & Brett, S. J. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000212 · Cited by 120
Self-citation
A Multibiomarker-Based Outcome Risk Stratification Model for Adult Septic Shock*
Wong, H. R., Lindsell, C. J., Pettilä, V., Meyer, N. J., Thair, S. A., Karlsson, S., Russell, J. A., Fjell, C. D., Boyd, J. H., Ruokonen, E., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0000000000000106 · Cited by 122
Self-citation
Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock
Coopersmith, C. M., Backer, D. D., Deutschman, C. S., Ferrer, R., Lat, I., Machado, F. R., Martin, G. S., Martín‐Loeches, I., Nunnally, M., Antonelli, M. M., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003225 · Cited by 117
Vasopressor Choice and Timing in Vasodilatory Shock
Wieruszewski, P. M., & Khanna, A. K. (2022) · Critical Care · doi:10.1186/s13054-022-03911-7 · Cited by 127
Phaeochromocytoma crisis
Whitelaw, B., Prague, J., Mustafa, O. G., Schulte, K., Hopkins, P. A., Gilbert, J. A., McGregor, A., & Aylwin, S. J. B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12324 · Cited by 115
Early Care of Adults With Suspected Sepsis in the Emergency Department and Out-of-Hospital Environment: A Consensus-Based Task Force Report
Yealy, D. M., Mohr, N. M., Shapiro, N. I., Venkatesh, A. K., Jones, A. E., & Self, W. H. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.02.006 · Cited by 123
Predicting and managing sepsis in burn patients: current perspectives
Lopez, O. N., Cambiaso‐Daniel, J., Branski, L. K., Norbury, W. B., & Herndon, D. N. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s119938 · Cited by 122
Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis
Li, Y., Li, H., & Zhang, D. (2020) · Critical Care · doi:10.1186/s13054-020-03204-x · Cited by 122
Two subphenotypes of septic acute kidney injury are associated with different 90-day mortality and renal recovery
Wiersema, R., Jukarainen, S., Vaara, S. T., Poukkanen, M., Lakkisto, P., Wong, H. R., Linder, A., van der Horst, I. C. C., & Pettilä, V. (2020) · Critical Care · doi:10.1186/s13054-020-02866-x · Cited by 115
The Heart in Sepsis: From Basic Mechanisms to Clinical Management
Rudiger, A., & Singer, M. (2013) · Current Vascular Pharmacology · doi:10.2174/1570161111311020008 · Cited by 118
The vasopressin and copeptin response to infection, severe sepsis, and septic shock*
Jochberger, S., Dörler, J., Luckner, G., Mayr, V. D., Wenzel, V., Ulmer, H., Morgenthaler, N. G., Hasibeder, W. R., & Dünser, M. W. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181957532 · Cited by 112
Therapeutic potential of HMGB1-targeting agents in sepsis
Wang, H., Zhu, S., Zhou, R., Li, W., & Sama, A. E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000884 · Cited by 115
Advances in the Management of Sepsis and the Understanding of Key Immunologic Defects
Skrupky, L. P., Kerby, P. W., & Hotchkiss, R. S. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31823422e8 · Cited by 112
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016)
Nishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 107
Pseudomonas aeruginosa -Catecholamine Inotrope Interactions
Freestone, P. P., Hirst, R. A., Sandrini, S. M., Sharaff, F., Fry, H., Hyman, S., & O'Callaghan, C. (2012) · Chest · doi:10.1378/chest.11-2614 · Cited by 107
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
Russell, J. A., Vincent, J.-L., Kjølbye, A. L., Olsson, H., Blemings, A., Spapen, H., Carl, P., Laterre, P.-F., & Grundemar, L. (2017) · Critical Care · doi:10.1186/s13054-017-1798-7 · Cited by 103
Self-citation
Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis
Trinder, M., Wang, Y., Madsen, C. M., Ponomarev, T., Bohunek, L., Daisely, B. A., Kong, H. J., Blauw, L. L., Nordestgaard, B. G., Tybjærg‐Hansen, A., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048568 · Cited by 110
Self-citation
Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms
Burgdorff, A.-M., Bucher, M., & Schumann, J. E. (2018) · Journal of International Medical Research · doi:10.1177/0300060517743836 · Cited by 113
Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026
Prescott, H. C., Antonelli, M. M., Alhazzani, W. A., Møller, M. H., Alshamsi, F. E., Azevedo, L. C. P., Belley‐Côté, E. P., Waele, J. D., Derde, L. P. G., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 149
Angiotensin II in septic shock
Corrêa, T. D., Takala, J. A., & Jakob, S. M. (2015) · Critical Care · doi:10.1186/s13054-015-0802-3 · Cited by 106
Therapeutic Strategies for High-Dose Vasopressor-Dependent Shock
Bassi, E., Park, M., & Azevedo, L. C. P. (2013) · Critical Care Research and Practice · doi:10.1155/2013/654708 · Cited by 106
A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock
Choudhury, A. K., Kedarisetty, C. K., Vashishtha, C., Saini, D., Kumar, S. A., Maiwall, R., Sharma, M. K., Bhadoria, A. S., Kumar, G., Joshi, Y. K., et al. (2016) · Liver International · doi:10.1111/liv.13252 · Cited by 101
Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: results from an open label randomised controlled clinical trial and a review of the literature
Wani, S. J., Mufti, S. A., Jan, R. A., Shah, S. U., Qadri, S. M., Khan, U. H., Bagdadi, F. S., Mehfooz, N., & Koul, P. A. (2020) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2020.1718200 · Cited by 104
Subphenotypes in acute kidney injury: a narrative review
Vaara, S. T., Bhatraju, P. K., Stanski, N. L., McMahon, B. A., Liu, K. D., Joannidis, M., & Bagshaw, S. M. (2022) · Critical Care · doi:10.1186/s13054-022-04121-x · Cited by 106
Clinical Approach to the Patient With AKI and Sepsis
Godin, M., Murray, P. T., & Mehta, R. L. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.003 · Cited by 102
Non-Hemodynamic Effects of Catecholamines
Hartmann, C., Radermacher, P., Wepler, M., & Nussbaum, B. L. (2017) · Shock · doi:10.1097/shk.0000000000000879 · Cited by 100
Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in Sepsis
Trinder, M., Genga, K. R., Kong, H. J., Blauw, L. L., Lo, C., Li, X., Cirstea, M. S., Wang, Y., Rensen, P. C. N., Russell, J. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1157oc · Cited by 98
Self-citation
American Burn Association Clinical Practice Guidelines on Burn Shock Resuscitation
Cartotto, R. C., Johnson, L. S., Savetamal, A., Greenhalgh, D. G., Kubasiak, J., Pham, T. N., Rizzo, J. A., Sen, S., & Main, E. (2023) · Journal of Burn Care & Research · doi:10.1093/jbcr/irad125 · Cited by 109
Impact of Low‐dose Vasopressin on Trauma Outcome: Prospective Randomized Study
Cohn, S. M., McCarthy, J., Stewart, R. M., Jonas, R. B., Dent, D. L., & Michalek, J. E. (2010) · World Journal of Surgery · doi:10.1007/s00268-010-0875-8 · Cited by 96
Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: A randomised controlled trial.
Annane, D., Maxime, V., Faller, J. P., Mezher, C., Clec'h, C., Martel, P., Gonzales, H., Feissel, M., Cohen, Y., Capellier, G., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002186 · Cited by 94
Association between intraoperative opioid administration and 30-day readmission: a pre-specified analysis of registry data from a healthcare network in New England
Long, D. R., Lihn, A.-L., Friedrich, S., Scheffenbichler, F. T., Safavi, K. C., Burns, S. M., Schneider, J. C., Grabitz, S. D., Houle, T. T., & Eikermann, M. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2017.12.044 · Cited by 96
Heparin-binding protein is important for vascular leak in sepsis
Bentzer, P., Fisher, J., Kong, H. J., Mörgelin, M., Boyd, J. H., Walley, K. R., Russell, J. A., & Linder, A. (2016) · Intensive Care Medicine Experimental · doi:10.1186/s40635-016-0104-3 · Cited by 95
Self-citation
The Japanese guidelines for the management of sepsis
Oda, S., Aibiki, M., Ikeda, T., Imaizumi, H., Endo, S., Ochiai, R., Kotani, J., Shime, N., Nishida, O., Noguchi, T., et al. (2014) · Journal of Intensive Care · doi:10.1186/s40560-014-0055-2 · Cited by 94
Sepsis-Induced Acute Kidney Injury
Mårtensson, J., & Bellomo, R. (2015) · Critical Care Clinics · doi:10.1016/j.ccc.2015.06.003 · Cited by 97
Mean arterial pressure and mean perfusion pressure deficit in septic acute kidney injury
Wong, B. T., Chan, M. J., Glassford, N. J., Mårtensson, J., Bion, V., Chai, S. Y., Oughton, C., Tsuji, I. Y., Lluch-Candal, C., & Bellomo, R. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.05.003 · Cited by 94
Vasopressin and its role in critical care
Sharman, A., & Low, J. (2008) · Continuing Education in Anaesthesia Critical Care & Pain · doi:10.1093/bjaceaccp/mkn021 · Cited by 94
Position Paper on the Reporting of Norepinephrine Formulations in Critical Care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force
Wieruszewski, P. M., Léone, M., Kaas‐Hansen, B. S., Dugar, S. P., Legrand, M. M., McKenzie, C., Bissell, B. D., Messina, A., Nasa, P., Schorr, C., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006176 · Cited by 95
Mean arterial pressure and vasopressor load after out-of-hospital cardiac arrest: Associations with one-year neurologic outcome
Laurikkala, J., Wilkman, E., Pettilä, V., Kurola, J. O., Reinikainen, M., Hoppu, S., Ala-Kokko, T. I., Tallgren, M. K., Tiainen, M., Vaahersalo, J., et al. (2016) · Resuscitation · doi:10.1016/j.resuscitation.2016.05.026 · Cited by 92
Precision Fluid Management in Continuous Renal Replacement Therapy
Murugan, R., Hoste, E. A. J., Mehta, R. L., Samoni, S., Ding, X., Rosner, M. H., Kellum, J. A., Ronco, C., & on behalf of the Acute Disease Quality Initiative (ADQI) Consensus Group (2016) · Blood Purification · doi:10.1159/000448528 · Cited by 92
Nonadherence to treatment protocol in published randomised controlled trials: a review
Dodd, S. R., White, I. R., & Williamson, P. R. (2012) · Trials · doi:10.1186/1745-6215-13-84 · Cited by 89
Challenges in the management of septic shock: a narrative review
Backer, D. D., Cecconi, M., Lipman, J., Machado, F. R., Myatra, S. N., Ostermann, M., Perner, A., Teboul, J., Vincent, J., & Walley, K. R. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05544-x · Cited by 95
Self-citation
The Cardiopulmonary Effects of Vasopressin Compared With Norepinephrine in Septic Shock
Gordon, A. C., Wang, N., Walley, K. R., Ashby, D., & Russell, J. A. (2012) · CHEST Journal · doi:10.1378/chest.11-2604 · Cited by 91
Self-citation
Postoperative blood pressure deficit and acute kidney injury progression in vasopressor-dependent cardiovascular surgery patients
Saito, S., Uchino, S., Takinami, M., Uezono, S., & Bellomo, R. (2016) · Critical Care · doi:10.1186/s13054-016-1253-1 · Cited by 93
The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials
Belletti, A., Benedetto, U., Biondi-Zoccai, G., Leggieri, C., Silvani, P., Angelini, G. D., Zangrillo, A., & Landoni, G. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.08.010 · Cited by 88
Early Peripheral Perfusion–guided Fluid Therapy in Patients with Septic Shock
van Genderen, M. E., Engels, N., van der Valk, R. J. P., Lima, A. A. P., Klijn, E., Bakker, J., & van Bommel, J. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1575le · Cited by 89
Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock
Thomas-Rüddel, D. O., Poidinger, B., Weiß, M., Bach, F., Dey, K., Haeberle, H. A., Kaisers, U. X., Rüddel, H., Schädler, D., Scheer, C., et al. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.10.027 · Cited by 89
Echocardiography as a guide for fluid management
Boyd, J. H., Sirounis, D., Maizel, J., & Slama, M. (2016) · Critical Care · doi:10.1186/s13054-016-1407-1 · Cited by 93
Vasopressor Therapy in the Intensive Care Unit
Russell, J. A., Gordon, A. C., Williams, M. D., Boyd, J. H., Walley, K. R., & Kissoon, N. “. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1710320 · Cited by 99
Self-citation
Microcirculatory dysfunction and resuscitation: why, when, and how
Moore, J. P. R., Dyson, A., Singer, M., & Fraser, J. F. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev163 · Cited by 93
The Attributable Mortality of Acute Kidney Injury
Vaara, S. T., Pettilä, V., Kaukonen, K., Bendel, S., Korhonen, A., Bellomo, R., & Reinikainen, M. (2013) · Critical Care Medicine · doi:10.1097/ccm.0000000000000045 · Cited by 89

Authors: Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., Cook, D. J., Presneill, J. J., & Ayers, D.
Affiliations: St. Paul's Hospital (CA)
University of Ottawa (CA)
The Alfred Hospital (AU)
University of British Columbia (CA)
Mount Sinai Hospital (CA)
University of Toronto (CA)
McMaster University (CA)
The Royal Melbourne Hospital (AU)
ORCID: Russell, James A.
Walley, Keith R.
Singer, Joel
Gordon, Anthony C.
Hébert, Paul C.
Cooper, D. James
Holmes, Cheryl L.
Mehta, Sangeeta
Granton, John T.
Presneill, Jeffrey J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-02-28
Volume: 358
Issue: 9
Pages: 877-887
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa067373
OpenAlex: W2108153775
Cited by: 1,924
References: 36
Citations by year: 2026: 106 · 2025: 119 · 2024: 101 · 2023: 91 · 2022: 88 · 2021: 85 · 2020: 104 · 2019: 205 · 2018: 114 · 2017: 104 · 2016: 100 · 2015: 83 · 2014: 91 · 2013: 84 · 2012: 89
FWCI: 88.86
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
Keywords: septic shock, vasopressin, norepinephrine, vasopressor therapy, catecholamines, mortality, 28-day mortality, 90-day mortality, sepsis treatment, blood pressure support, adverse events, subgroup analysis
MeSH terms: Adult, Aged, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Norepinephrine, Severity of Illness Index, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Failure, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks